Alivus Life Sciences Peer Comparison

Alivus Life Sciences Ltd. shows no growth and zero profitability metrics, positioning it at the bottom of the sector. However, peers like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. are strong performers with solid growth, profitability, and reasonable valuations, indicating a robust industry despite the underperformance of the target company.

• • Alivus Life Sciences Ltd. has zero revenue and profit metrics, indicating no growth or returns.
• • Sun Pharmaceuticals and Dr. Reddy's Laboratories emerge as sector leaders with high ROE and revenue growth.
• • Alivus is overvalued at a PE of 23.66 with no earnings, while peers show better valuations relative to their growth.

• • Sun Pharmaceutical Industries Ltd.: Strong revenue growth (8.42% YoY) and ROE (16.13%), but high PE ratio (87.59) making it less attractive on valuation.
• • Dr. Reddy's Laboratories Ltd.: Excellent profitability metrics with a PE of 15.50 and high ROE (21.76%), making it both a growth and value pick.
• • Cipla Ltd.: Strong growth (13.28% YoY) and low PE (23.73) with solid ROE (16.63%), indicating a balanced position.